A clinical analysis of 17 AD patients and 14 healthy people indicated that CD4+ T cells, specifically effector memory T cells and Tregs, demonstrated enhanced TIGIT expression on the patients’ PBMCs and that the proportion of TIGIT+ cells was correlated with AD severity (77). The gene discussed is CD4; the disease is Alzheimer disease.